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MaOBJECTIVES This study was performed to determine the accuracy of right ventricular (RV) longitudinal strain (LS)
in predicting myocardial ﬁbrosis in patients with severe heart failure (HF) undergoing heart transplantation.
BACKGROUND RVLS plays a key role in the evaluation of its systolic performance and clinical outcome in patients with
refractory HF.
METHODS We studied 27 patients with severe systolic HF (ejection fraction #25% and New York Heart Association
functional class III to IV, despite full medical therapy and cardiac resynchronization therapy) using echocardiography
before heart transplantation. RV free wall LS, right atrial LS, sphericity index (SI), and tricuspid annular plane systolic
excursion (TAPSE) were all measured. Upon removal of the heart, from the myocardial histologic analysis, the ratio of the
ﬁbrotic to the total sample area determined the extent of ﬁbrosis (%).
RESULTS RV myocardial ﬁbrosis correlated with RV free wall LS (r ¼ 0.80; p < 0.0001), SI (r ¼ 0.42; p ¼ 0.01) and VO2
max (r ¼ –0.41; p ¼ 0.03), with a poor correlation with TAPSE (r ¼ –0.34; p ¼ 0.05) and right atrial LS (r ¼ –0.37;
p ¼ 0.03). Stepwise multivariate analysis showed that RV free wall LS (b ¼ 0.701, p < 0.0001) was independently
associated with RV ﬁbrosis (overall model R2 ¼ 0.64, p < 0.0001). RV free wall LS was the main determinant of
myocardial ﬁbrosis. In the subgroup of patients with severe RV ﬁbrosis, RV free wall LS had the highest diagnostic
accuracy for detecting severe myocardial ﬁbrosis (area under the curve ¼ 0.87; 95% conﬁdence interval: 0.80 to 0.94).
CONCLUSIONS In late-stage HF patients, the right ventricle is enlarged, with reduced systolic function due to sig-
niﬁcant myocardial ﬁbrosis. RV free wall myocardial deformation is the most accurate functional measure that correlates
with the extent of RV myocardial ﬁbrosis and functional capacity. (J Am Coll Cardiol Img 2015;8:514–22) © 2015 by the
American College of Cardiology Foundation.R ight ventricular (RV) systolic function is animportant prognostic factor in heart failure(HF) with longitudinal systolic amplitude
of motion and myocardial strain predicting exer-
cise capacity and survival (1–4). Such measure-
ments of RV free wall have proved essential in
contributing to 80% of its stroke volume and
are able to explain the cavity adaptive mecha-
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also occurs in RV failure in pulmonary arterial hy-
pertension, which in late stages is associated with
progressive leftward septal displacement (6,7).
The aim of this study was to determine the value
of right ventricular longitudinal strain (RVLS) in
predicting the extent of RV myocardial ﬁbrosis in
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AB BR E V I A T I O N S
AND ACRONYM S
CRT = cardiac
resynchronization therapy
HF = heart failure
NT-proBNP = N-terminal
pro-hormone of brain
natriuretic peptide
NYHA = New York Heart
Association
ROC = receiver operating
characteristic
TAPSE = tricuspid annular
plane systolic excursion
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STUDY POPULATION. We enrolled 27 patients with
end-stage HF (left ventricular [LV] ejection
fraction #25%; New York Heart Association [NYHA]
functional class III to IV despite full medical therapy
and cardiac resynchronization therapy [CRT]),
referred to Le Scotte Hospital of Siena for a simulta-
neous right heart catheterization and echocardio-
graphic evaluation before HT (8,9).
Tissue samples of the RV free wall were obtained
from explanted hearts. Patients were excluded if they
were not in sinus rhythm, on mechanical ventilation,
had severe mitral/tricuspid regurgitation, other valve
disease, or suboptimal echocardiographic image
quality. Patients’ echocardiographic results were
compared with those from 25 controls, none of whom
had a cardiac condition or history of any systemic
disease. Patients and controls gave written informed
consent before participating in the study. The project
complied with the declaration of Helsinki and had
been approved by the local ethics committee.SEE PAGE 523STANDARD ECHOCARDIOGRAPHY. All echocardio-
graphic examinations were performed according to
the recommendations of the American and European
Society of Echocardiography (10,11). Studies were
performed using Vivid 7, GE Medical System echo-
cardiograph (Horten, Norway), equipped with an
adult 1.5- to 4.3-MHz phased array transducer, and an
echocardiogram continuously displayed. LV ejection
fraction was calculated from the apical views using
the biplane modiﬁed Simpson method (10) and LV
mass using the Penn formula (12) and was indexed to
body surface area (BSA).
LV DIASTOLIC FUNCTION. Pulsed-wave Doppler
velocities of LV ﬁlling were recorded from the apical
4-chamber view by placing the sample volume by the
tips of the mitral leaﬂets. Early (E) and late (A) dia-
stolic LV ﬁlling velocities were registered and E/A
ratio was calculated (13) and used as standard index
of LV diastolic function (14). The LV ﬁlling pattern
was considered restrictive when the E/A ratio was
>2.0, E-wave deceleration time <140 ms, and the left
atrium dilated, and >40 mm in diameter (15). Raised
E/e’ was also taken as a marker of raised ﬁlling pres-
sures (16). The same method was used to obtain RV
ﬁlling velocities and measurements (17).
RV MEASUREMENTS. RV volume was measured from
the 4-chamber view at end-diastole. The mid-cavity
diameter was measured in the middle third at the
level of the LV papillary muscles (18).RV LONGITUDINAL FUNCTION. RV longitu-
dinal function was studied using the pulsed
tissue Doppler imaging technique with the
sample volume at the level of tricuspid lateral
annulus from the apical 4-chamber view (19).
Peak systolic (s’), early diastolic (e’), and
late diastolic (a’) tricuspid annular velocities
were obtained. s’ is considered to be a rela-
tively load-independent index of RV longi-
tudinal systolic function, and e’ and e’/a’
ratio are considered to be load-independent
markers of diastolic relaxation. Tricuspid
annular plane systolic excursion (TAPSE) was
measured with the cursor placed at the lateral
angle of the annulus from the apical 4-chamber
view (20).
LV AND RV LONGITUDINAL MYOCARDIAL INTRINSIC
FUNCTION. LV and RV myocardial function was
studied using speckle tracking echocardiography of
the apical long axis, obtained from the apical 4- and
2-chamber views, during a quiet breath hold, with a
frame rate of 60 to 80 per s. Three consecutive heart
cycles were recorded and averaged. The off-line
analysis was performed using a commercially avail-
able semiautomated 2-D strain software (EchoPac,
GE, Waukesha, Wisconsin).
The peak LV longitudinal strain (LS) was deﬁned as
the peak negative value on the strain curve. The LV
cavity was traced manually from the innermost endo-
cardial edge at end-systole, and the software auto-
matically deﬁned the LS throughout the cardiac cycle.
LS was analyzed ﬁrst in the apical long axis viewwhere
the closure of the aortic valve was deﬁned with respect
to the R wave to mark end-systole. Then the same
process was used for the 4-chamber and 2-chamber
views. The automated algorithm provided the longi-
tudinal peak systolic strain value for each LV segment
from a 17-segment model polar plot and an average
value for the 3 apical views (LV global LS) (21).
Calculation of RV free wall LS was obtained with
the same method delineating a region of interest
composed of three segments of the lateral wall: basal,
mid-cavity, and apical. After segmental tracking, the
RV LS curves were generated by the software and the
average value of LS was calculated (22) (RV free wall
LS [Figure 1]).
RV SYSTOLIC FUNCTION. RV sphericity index (SI),
was calculated at end-diastole by dividing the short
axis by the long-axis diameters (18,23).
RIGHT ATRIAL STRUCTURE AND FUNCTION. Right
atrial (RA) area and volume were measured using the
biplane method of disks in the apical 4-chamber view
at end-systole (10) and were indexed to BSA. RA
TABLE 2 Patient Catheterization Data (n ¼ 27)
Systolic blood pressure, mm Hg 103.0  9.0
Diastolic blood pressure, mm Hg 69.0  9.0
Mean PAP, mm Hg 28.7  7.8
Systolic PAP, mm Hg 39.4  6.8
Diastolic PAP, mm Hg 19.3  3.7
PAoP, mm Hg 22.7  6.3
CI therm, ml/min/m2 2.1  0.4
CI Fick, ml/min/m2 1.98  0.3
RVSWI, mm Hg/l $ m2 0.23  0.07
Values are mean  SD.
CI therm ¼ cardiac index estimated by thermodilution; PAoP ¼ pulmonary artery
occlusion pressure; PAP ¼ pulmonary arterial pressure; RVSWI ¼ right ventricular
stroke work index.
TABLE 1 Patient Clinical Data (n ¼ 27)
Hypertension 20 (74)
Diabetes mellitus 8 (30)
Hypercholesterolemia 19 (70)
Current smoker 2 (7)
NYHA functional class
III 15 (55)
IV 12 (45)
Cardiomyopathy
Ischemic 16 (59)
Idiopathic 10 (37)
Hypertrophic cardiomyopathy 1 (4)
Medical therapy
ACE-inhibitors or ARB 27 (100)
Beta-blockers 25 (93)
Aldosterone antagonists 10 (37)
Loop diuretics 27 (100)
Statins 19 (70)
Amiodarone 11 (41)
Digitalis 6 (22)
CRT-D 11 (41)
Laboratory data
Hemoglobin (g/dl) 12.6  1.9
Creatinine (mg/dl) 1.28  0.53
Urea (mg/dl) 64.2  39.7
NT-proBNP (pg/ml) 3,846.6  3,213.8
Values are n (%) or mean  SD.
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blocker;
CRT-D ¼ cardiac resynchronization therapy and deﬁbrillation implantation;
NT-proBNP ¼ N-terminal pro-hormone of brain natriuretic peptide; NYHA ¼
New York Heart Association.
FIGURE 1 Measurement of Right Ventricular Free Wall Longitudinal Strain
The dashed curve represents the average LS of only free wall RV segments along the
cardiac cycle. LS ¼ longitudinal strain; RV ¼ right ventricular; AVC ¼ aortic valve closure.
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516myocardial function was studied from the apical
4-chamber view using the same methods applied for
the RV and same frame rate. The RA endocardial
border was manually traced, thus delineating a region
of interest composed of 6 segments. RA peak atrial
longitudinal strain (RALS), measured at the end of the
reservoir phase, was calculated by averaging values
obtained from all segments (global RALS) (24).
RIGHT HEART CATHETERIZATION. The hemody-
namic measurements were performed before the HT.
The pressure transducers were balanced before data
acquisition with the zero level at mid-axillary line.
Pulmonary artery (PA) catheters were used to mea-
sure PA pressure (PAP), central venous pressure and
RV stroke volume (RVSV), derived by the thermodi-
lution technique (average of 5 cardiac cycles with
<10% variation) and by the Fick equation through
the sampling of a mixed central venous blood gas
obtained from the PA and an arterial blood gas. RV
stroke volume index (RVSVI) was calculated by
dividing the RVSV by BSA. RV stroke work index
(RVSWI) was derived as:
RVSWI ¼ RVSVI  ðPAPm  RAPmÞ
where PAPm is mean PAP and RAPm is mean RA
pressure. A RVSWI value of 0.25 mm Hg/l $ m2
detected impaired RV function (25).
N-TERMINAL PRO-HORMONE OF BRAIN NATRIURETIC
PEPTIDE MEASUREMENT. N-terminal pro-hormone of
brain natriuretic peptide (NT-proBNP) was assessed
at the time of the right heart catheterization from a
peripheral venous blood sample collected in heparin-
containing tubes and measured using an electro-
chemiluminescence immunoassay and the analyticrange of the NT-proBNP assay spanned from 5 to
35,000 pg/ml.
CARDIOPULMONARY EXERCISE TEST. Before HT, all
patients underwent a maximum cardiopulmonary
exercise testing in a lower-limb cycle ergometer
(Inbrasport CG-04, Porto Alegre, Brazil), using a
graded exercise test with an incremental protocol of
25 watts every minute until exhaustion or symptom
development (American Thoracic Society/American
TABLE 3 Echocardiographic Data of the Study Population
Healthy Subjects
(n ¼ 25)
Patients
(n ¼ 27) p Value
Female 38 30 ns
Age, yrs 51.8  6.7 53.7  4.6 ns
Heart rate, beats/min 76.9  9.6 79.2  11.2 ns
Body mass index, kg/m2 25.9  1.9 24.5  2.2 ns
Body surface area, m2 1.87  0.6 1.99  0.2 ns
End-diastolic LV volume, ml 81.7  11.4 225.4  78.2 <0.0001
LV ejection fraction, % 61.4  1.9 22.3  2.4 <0.0001
LV global LS, % 21.2  1.9 8.0  5.1 <0.0001
LV mass index, g/m2 72.7  12.3 121.8  19.9 <0.0001
Right heart parameters
Mid-ventricular EDD, mm 24.3  6.2 39.8  4.1 0.002
TAPSE, mm 24.6  3.4 13.3  4.1 0.001
SI 0.36  0.04 0.51  0.07 <0.001
RV length, cm 7.3  0.6 7.9  0.9 ns
Tricuspid E/A ratio 1.67  0.4 1.08  0.9 0.008
Tricuspid s0, cm/s 14.2  2.1 10.6  2.9 0.003
Tricuspid e0, cm/s 13.5  1.9 9.4  0.9 0.001
Tricuspid a0, cm/s 15.6  2.2 11.2  1.2 0.009
Tricuspid e0/a0 0.94  0.1 0.83  0.2 0.03
RV free wall LS, % 29.7  4.7 15.3  4.7 <0.0001
RA area, cm2 14.6  2.4 24.7  3.3 0.006
RALS, % 40.2  12.4 12.2  5.5 <0.0001
Values are % or mean  SD.
A ¼ atrial trans-tricuspid ﬂow velocity; E ¼ early trans-tricuspid ﬂow velocity; e’ ¼ early dia-
stolic tricuspid annular velocity; EDD ¼ end-diastolic diameters; LS ¼ longitudinal strain; LV¼ left
ventricular; ns ¼ not signiﬁcant; RA ¼ right atrial; RALS ¼ right atrial longitudinal strain; RV ¼
right ventricular; s’ ¼ tricuspid systolic annular velocity; SI ¼ sphericity index; TAPSE ¼ tricuspid
annular plane systolic excursion.
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517College of Chest Physicians statement). Oxygen
saturation was monitored with pulse oximeter and
12-lead electrocardiogram monitoring was recorded
throughout the test. Blood pressure was taken before
and at peak exercise. Furthermore, using arterial
and venous blood gas analysis we obtained oxygen
concentrations at rest and at peak exercise.
During the cardiopulmonary exercise, the exhaled
gases were collected by a pneumotachograph
attached to a mouthpiece, with concomitant nasal
occlusion, and was quantiﬁed by a metabolic analyzer
(MedGraphics, St. Paul, Minnesota). Gas analysis
measurements; oxygen consumption (VO2), carbon
dioxide production, tidal volume, respiratory rate,
and minute ventilation were all made. Maximal VO2
(VO2 max) was deﬁned by the Fick equation as the
product of cardiac output and arterio-venous oxygen
difference [C(a-v)O2] at peak exercise:
VO2 max ¼ ðHR  SVÞ  ½Cða vÞO2
where HR is heart rate and SV is stroke volume. VO2
max was measured every minute of exercise, as aver-
age of 6 readings and was presented as liter/minute.
HISTOPATHOLOGICAL ANALYSIS. Samples of the RV
free wall were obtained after removing the heart. For
each patient, 3 full-thickness slices of the RV (basal,
mid-cavity, and apical) were obtained and the extent
of myocardial ﬁbrosis was calculated as the average of
the 3 slices. This analysis was performed to better
compare the extent of myocardial ﬁbrosis with RV
whole free wall LS strain. Tissue samples were sub-
sequently prepared for histopathological examina-
tion. The average sample dimension was 1  0.5 cm
which was subsequently ﬁxed in 10% buffered
formalin, embedded in parafﬁn, and cut into slices of
4-mm thick for hematoxylin-eosin and Masson’s tri-
chrome staining. For Masson’s staining, slices were
de-waxed with xylol (2 steps, 2 minutes each and
soaked into a series of a gradient concentrations from
99% to 95% of alcohol). All slices were washed in
distilled water and put in a solution of hematoxylin
for 3 min. Subsequently, color change was performed
with lithium carbonate (0.1%) to steer the hematox-
ylin staining. Slices were washed in pure water and
colored with Red Ponceau staining (oven at 30C for
20 s at 45 KW) then put in acid water and phospho-
molybdic acid (1 min). The last stage included the
addition of green-light and washing with acid water.
The ratio of the ﬁbrosis area to the total sample area
of each section was used to assess the degree of RV
ﬁbrosis (%) as (ﬁbrosis area-total area)  100 (26).
RV STRAIN MEASUREMENT REPRODUCIBILITY. The
software was able to track 146 of 156 (94%) acquiredRV segments. Ten patients were randomly selected
and Bland-Altman analysis was performed to eval-
uate the intraobserver and interobserver variability,
demonstrating a good agreement with small bias of
0.6  2.9% and 0.8  4.1%, respectively.
STATISTICAL ANALYSIS. Data are shown as mean 
SD. A p value <0.05 was considered statistically sig-
niﬁcant. Analyses were performed using the SPSS
(Statistical Package for the Social Sciences, Chicago,
Illinois) software Release 11.5. Pearson’s correlation
coefﬁcients were calculated to assess the relationship
between continuous variables. The sensitivity and
speciﬁcity were calculated using standard deﬁnition,
receiver operating characteristic curves were con-
structed, and area under the curve was calculated
for the prediction of severe RV myocardial ﬁbrosis.
Multiple regression analysis was performed to ex-
plore the independent determinants of RV ﬁbrosis.
RESULTS
Patient’s mean peak VO2 was 11.2  1.7 ml/kg/min
(I quartile: 9.8 ml/kg/min; II quartile: 11.2 ml/kg/min
FIGURE 2 Measurement of RV Free Wall LS in a Heart Failure Patient
(A) The dashed curve represents the average LS of only free wall RV segments along the cardiac cycle. (B) RV free wall biopsy in the same patients (original
magniﬁcation: 50). Abbreviations as in Figure 1.
FIGURE 3 A Diagram Showing the Increase of Myocardial Fibrosis and the Parallel Reduction of RV Free Wall LS
The dashed curve represents the average LS of only free wall RV segments along the cardiac cycle. (For RV free wall biopsy, original magniﬁcation: 50.) Abbreviations
as in Figure 1.
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FIGURE 4 Diagnostic Accuracy of Noninvasive Estimate of
Severe RV Myocardial Fibrosis
Receiver operating characteristic (ROC) curves for RV free wall LS.
Abbreviations as in Figure 1.
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519[also the median], III quartile: 12.8 ml/kg/min;
IV quartile: 14.6 ml/kg/min). They had reduced ex-
ercise capacity (NYHA functional class III to IV) and
elevated NT-proBNP value (I quartile: 1,545 pg/ml;FIGURE 5 Correlation Between RV Myocardial Fibrosis and
RV Free Wall LS in All Patients
Abbreviations as in Figure 1.II quartile: 3,362 pg/ml [also the median], III quar-
tile: 5,145 pg/ml; IV quartile: 10,479 pg/ml) (Table 1).
Right heart catheterization data are listed in Table 2.
Patients underwent HT 22  14 days after the echo-
cardiographic examination. Seventeen patients (63%)
had severe RV myocardial ﬁbrosis (>50%).
PATIENTS VERSUS CONTROLS. Compared to con-
trols, patients had higher LV mass index (p < 0.0001),
reduced ejection fraction (p < 0.0001) (inclusion cri-
terion) and reduced LV global LS (p < 0.0001). LV e0
was lower (p ¼ 0.002), whereas E/A and E/e0 were
higher (p < 0.0001 for both) (Table 3).
Patients had increased RV inlet diameter (p ¼
0.002). RV SI was increased (p < 0.001), and E/A and
e0/a0 (p ¼ 0.008 and p ¼ 0.03, respectively) were lower
than controls. They also had reduced TAPSE and s0
(p ¼ 0.001 and p ¼ 0.003, respectively) and RV free
wall LS (p < 0.0001 for both) and increased RA area
(p ¼ 0.006) with severely reduced RALS (p < 0.0001).
RV FUNCTION VERSUS FIBROSIS. RV myocardial
ﬁbrosis correlated with free wall LS (r ¼ 0.80; p <
0.0001), SI (r ¼ 0.42; p ¼ 0.01) and VO2 max (r ¼ –0.41;
p ¼ 0.03), with a poor correlation with TAPSE
(r ¼ –0.34; p ¼ 0.05) and RALS (r ¼ –0.37; p ¼ 0.03)
(Figures 2 to 5, Table 4).
Stepwise multivariate analysis showed that RV free
wall LS (b ¼ 0.701, p < 0.0001) was independently
associated with RV ﬁbrosis (overall model R2 ¼ 0.64,
p < 0.0001). RV free wall LS was the main determi-
nant of myocardial ﬁbrosis.
In the subgroup of patients with severe RV ﬁbrosis,
myocardial ﬁbrosis correlated with free wall LS
(r ¼ 0.72; p < 0.0001), SI (r ¼ 0.47; p < 0.0001), RALS
(r ¼ –0.46; p ¼ 0.005), and VO2 max (r ¼ –0.44,
p ¼ 0.01) with a poor correlation with TAPSE
(r ¼ –0.32; p ¼ 0.01). RV free wall LS had the highest
diagnostic accuracy for detecting severe myocardial
ﬁbrosis (area under the curve [AUC] ¼ 0.87; 95%
conﬁdence interval: 0.80 to 0.94).
LV FUNCTION VERSUS EXERCISE CAPACITY. There
was no relationship between LV myocardial defor-
mation (global LS) and exercise capacity (VO2 max)
(R ¼ –0.29; p ¼ ns).
DISCUSSION
The ﬁndings of this study can be summarized as
follows: 1) in patients with end-stage HF, the RV is
signiﬁcantly enlarged with reduced systolic function;
and 2) RV free wall LS is the best echocardiographic
measure that correlates with the extent of myocardial
ﬁbrosis.
TABLE 4 RV Free Wall Myocardial Fibrosis and RV Free Wall LS
in All Patients
Patient #
RV Free
Wall LS (%)
RV Free Wall
Myocardial Fibrosis (%)
1 16.56 58
2 10.31 53
3 12.54 59
4 15.47 58
5 11.25 65
6 11.58 56
7 19.22 58
8 16 54
9 9 70
10 15 59
11 12.2 61
12 8.2 65
13 7.7 69
14 3.58 71
15 17.72 43
16 17.9 45
17 21.88 55
18 18.52 53
19 13.1 53
20 18.9 41
21 20.2 32
22 18.9 39
23 19.4 41
24 19.5 37
25 18.7 45
26 19.8 31
27 20.7 32
Values are (%).
Abbreviations as in Table 3.
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520DATA INTERPRETATION. RV function in the form of
reduced TAPSE has been shown to correlate with
exercise capacity and to predict survival in patients
with dilated cardiomyopathy and reduced LV systolic
function (5,27). In the current study we have
conﬁrmed these ﬁndings in a group of patients with
end-stage HF requiring HT. This gave us a unique
opportunity to assess the extent of RV free wall
ﬁbrosis histologically, having considered >50% of the
myocardial sample as severe ﬁbrosis and compared it
with the pattern and extent of RV dysfunction.
Among a full battery of RV structure and function
measurements, we identiﬁed free wall LS as the best
predictor of the extent of myocardial ﬁbrosis. Finally,
the same parameter predicted the limited exercise
tolerance in these patients. Thus, the reduced free
wall strain, usually described as impaired intrinsic
myocardial function, in fact reﬂects the severity of
segmental ﬁbrosis. Interestingly, there was no similar
relationship between LV function and the extent of
its myocardial ﬁbrosis.End-stage myocardial adaptation process is mostly
in the form of collagen formation and ﬁbrosis, which
when mild, disturbs organ function but when severe
it may have signiﬁcant systemic implications (28).
RV response to preload, afterload, or primary
myocardial pathology is by cavity enlargement due to
its remarkable thin walls compared to the left
ventricle (5,6). A behavior that results in signiﬁcant
disturbances to myocardial ﬁber architecture and
interstitial tissue remodeling, localized inﬂammatory
processes, then eventually collagen formation (29)
and ﬁbrosis as we have shown. When in a small per-
centage, the viable segments take over the function,
but when severe it results in raised end-diastolic
pressure, as was the case in our patients. Because
ﬁbrosis is irreversible, it explains the intractable
clinical picture of our patients who needed trans-
plantation. Furthermore, in patients with severe
myocardial ﬁbrosis, the reduction of functional ca-
pacity (VO2) was closely related to the compromised
myocardial performance in the form of RV free wall
LS, again supporting the essential role of the RV lon-
gitudinal myocardial function in determining symp-
toms and prognosis of HF (30,31). Unfortunately, our
results were unable to ascertain the role of RV free
wall LS in establishing the exact levels of function
impairment that determine disease progression, from
early symptom development to a need for cardiac
transplantation, because of the selection bias.
CLINICAL IMPLICATION. This study shows that RVLS
is able to estimate RV systolic performance and to
predict the extent of myocardial ﬁbrosis in patients
with end-stage HF requiring cardiac transplantation.
These data can be useful to guide towards optimal
medical therapy in HF patients and to identify pa-
tients with RV dysfunction before they develop se-
vere irreversible myocardial ﬁbrosis. Having such
sensitivity, RV free wall LS could be used to identify
patients likely to respond to more aggressive medical
treatment, i.e., pressure ofﬂoading, compared to
those needing an LV assist device implantation (32).
Even in the latter, RV free wall LS might stratify pa-
tients needing cardiac transplantation rather than a
hope for recovery by LV assist device (30).
STUDY LIMITATIONS. The measurements of global
and free wall RVLS depend on adequate 2-dimensional
apical views to permit an easy delineation of the
RV endocardial border and to permit the visualiza-
tion of the entire RV free wall. Despite these limi-
tations, the RV speckle tracking echocardiography
analysis was performed in all patients with good
reproducibility. Our study has a limited patient
number, despite being a homogenous population.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: In patients with
end-stage HF the RV is enlarged and its systolic function is
severely compromised due to signiﬁcant ﬁbrosis. RV free wall
longitudinal strain is the most accurate echocardiographic
measure that correlates with the extent of myocardial ﬁbrosis.
TRANSLATIONAL OUTLOOK: If conﬁrmed in large future
longitudinal studies, RV freewall longitudinal strainmight assist in
stratifying patients who need transplantation contrary to those
who might beneﬁt from assist devices as a bridge to recovery.
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521Eleven patients (41%) had CRT and RV leads, and
although this could affect RV systolic and diastolic
time relations, it is unlikely to alter intrinsic
myocardial function. This claim is supported by
previous studies showing that RV apical pacing did
not affect RV systolic function, despite induction of
electromechanical dyssynchrony (33). Finally, our
results cannot propose a cut-off value for RVLS
because absolute measurements may be vendor
dependent.
CONCLUSIONS
In late-stage HF patients, the right ventricle is
enlarged with reduced systolic function due to sig-
niﬁcant myocardial ﬁbrosis. RV free wall myocardial
deformation is the most accurate functional measure
that correlates with the extent of RV myocardial
ﬁbrosis and functional capacity.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Matteo Lisi, Department of Cardiovascular Disease,
University of Siena, Policlinico Le Scotte, Viale Bracci
1, 53100 Siena, Italy. E-mail: matteo.lisi@hotmail.it.RE F E RENCE S1. Byström B, Lindqvist P, Henein M. The right
ventricle: knowing what is right. Int J Cardiovasc
Imaging 2008;24:701–2.
2. Donal E, Coquerel N, Bodi S, et al. Importance
of ventricular longitudinal function in chronic
heart failure. Eur J Echocardiogr 2011;12:619–27.
3. Cameli M, Lisi M, Righini FM, et al. Right ven-
tricular longitudinal strain correlates well with
right ventricular stroke work index in patients with
advanced heart failure referred for heart trans-
plantation. J Card Fail 2012;18:208–15.
4. Cameli M, Bernazali S, Lisi M, et al. Right ven-
tricular longitudinal strain and right ventricular
stroke work index in patients with severe heart
failure: left ventricular assist device suitability for
transplant candidates. Transplant Proc 2012;44:
2013–5.
5. Fang F, Henein MY, Yu CM, et al. Right ven-
tricular long-axis response to different chronic
loading conditions: its relevance to clinical symp-
toms. Int J Cardiol 2013;167:378–82.
6. Mauritz GJ, Kind T, Marcus JT, et al. Progressive
changes in right ventricular geometric shortening
and long-term survival in pulmonary arterial hy-
pertension. Chest 2012;141:935–43.
7. Zhao Y, Henein MY, Mörner S, Gustavsson S,
Holmgren A, Lindqvist P. Residual compromised
myocardial contractile reserve after valve
replacement for aortic stenosis. Eur Heart J Car-
diovasc Imaging 2012;13:353–60.
8. Mehra MR, Kobashigawa J, Starling R, et al.
Listing criteria for heart transplantation: Interna-
tional Society for Heart and Lung Transplantation
guidelines for the care of cardiac transplant
candidates—2006. J Heart Lung Transplant 2006;
25:1024–42.
9. Francis GS, Greenberg BH, Hsu DT. ACCF/AHA/
ACP/HFSA/ISHLT 2010 clinical competence state-
ment on management of patients with advancedheart failure and cardiac transplant: a report
of the ACCF/AHA/ACP Task Force on clinical
competence and training. J Am Coll Cardiol 2010;
56:424–53.
10. Lang RM, Bierig M, Devereux RB, et al. Rec-
ommendations for chamber quantiﬁcation: a
report from the American Society of Echo-
cardiography’s Guidelines and Standards Commit-
tee and the Chamber Quantiﬁcation Writing Group,
developed in conjunction with the European As-
sociation of Echocardiography, a branch of the
European Society of Cardiology. J Am Soc Echo-
cardiogr 2005;18:1440–63.
11. Gottdiener JS, Bednarz J, Devereux R, et al.
American Society of Echocardiography recom-
mendations for use of echocardiography in
clinical trials. J Am Soc Echocardiogr 2004;17:
1086–119.
12. Devereux RB, Reicheck N. Echocardiographic
determination of left ventricular mass: anatomic
validation of the method. Circulation 1977;55:613–8.
13. Nagueh SF, Appleton CP, Gillebert TC. Rec-
ommendations for the evaluation of left ventric-
ular diastolic function by echocardiography. Eur J
Echocardiogr 2009;10:165–93.
14. Quinones MA, Otto CM, Stoddard M,
Waggoner A, Zoghbi WA. Recommendations for
quantiﬁcation of Doppler echocardiography: a
report from the Doppler quantiﬁcation task force
of the Nomenclature and Standards Committee of
the American Society of Echocardiography. J Am
Soc Echocardiogr 2002;15:167–84.
15. Nishimura RA, Tajik AJ. Evaluation of
diastolic ﬁlling of left ventricle in health and
disease: Doppler echocardiography is the clinician’s
Rosetta Stone. J Am Coll Cardiol 1997;30:8–18.
16. Ommen SR, Nishimura RA, Appleton CP, et al.
Clinical utility of Doppler echocardiography and
tissue Doppler imaging in the estimation of leftventricular ﬁlling pressures: a comparative simul-
taneous Doppler-catheterization study. Circulation
2000;102:1788–94.
17. Sade LE, Gulmez O, Eroglu S, Sezgin A,
Muderrisoglu H. Noninvasive estimation of right
ventricular ﬁlling pressure by ratio of early
tricuspid inﬂow to annular diastolic velocity in
patients with and without recent cardiac surgery.
J Am Soc Echocardiogr 2007;20:982–8.
18. Rudski LG, Lai WW, Aﬁlao J, et al. Guidelines
for the echocardiographic assessment of the right
heart in adults: a report from the American Society
of Echocardiography endorsed by the European
Association of Echocardiography, a registered
branch of the European Society of Cardiology, and
the Canadian Society of Echocardiography. J Am
Soc Echocardiogr 2010;23:685–713.
19. Yu CM, Sanderson JE, Marwick, Oh JK. Tissue
Doppler imaging a new prognosticator for car-
diovascular disease. J Am Coll Cardiol 2007;49:
1903–14.
20. Lindqvist P, Calcutteea A, Henein M. Echo-
cardiography in the assessment of right heart
function. Eur J Echocardiogr 2008;9:225–34.
21. Mondillo S, Galderisi M, Mele D, et al., Echo-
cardiography study group of the Italian Society of
Cardiology (Rome, Italy). Speckle tracking echo-
cardiography: a new technique for assessing
myocardial function. J Ultrasound Med 2011;30:
71–83.
22. Meris A, Faletra F, Conca C, et al. Timing and
magnitude of regional right ventricular function: a
speckle tracking-derived strain study of normal
subjects and patients with right ventricular
dysfunction. J Am Soc Echocardiogr 2010;23:
823–31.
23. Kim HK, Kim YJ, Park JS, et al. Determinants of
the severity of functional tricuspid regurgitation.
Am J Cardiol 2006;98:236–42.
Lisi et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 5 , 2 0 1 5
Right Ventricular Fibrosis in Heart Failure M A Y 2 0 1 5 : 5 1 4 – 2 2
52224. Cameli M, Lisi M, Righini FM, Mondillo S. Novel
echocardiographic techniques to assess left atrial
size, anatomy and function. Cardiovasc Ultrasound
2012;1:10–4.
25. Matthews JC, Koelling TM, Pagani FD,
Aaronson KD. The right ventricular failure risk
score. A pre-operative tool for assessing the risk of
right ventricular failure in left ventricular assist
device candidates. J Am Coll Cardiol 2008;51:
2163–72.
26. Cameli M, Lisi M, Righini FM, et al. Usefulness
of atrial deformation analysis to predict left atrial
ﬁbrosis and endocardial thickness in patients un-
dergoing mitral valve operations for severe mitral
regurgitation secondary to mitral valve prolapse.
Am J Cardiol 2013;111:595–601.
27. Tan JL, Prati D, Gatzoulis MA, Gibson D,
Henein MY, Li W. The right ventricular response
to high afterload: comparison between atrial
switch procedure, congenitally correctedtransposition of the great arteries, and idiopathic
pulmonary arterial hypertension. Am Heart J
2007;153:681–8.
28. Plaksej R, Kosmala W, Frantz S, et al. Relation
of circulating markers of ﬁbrosis and progression
of left and right ventricular dysfunction in hyper-
tensive patients with heart failure. J Hypertens
2009;27:2483–91.
29. Munkhammar P, Carlsson M, Arheden H,
Pesonen E. Restrictive right ventricular physi-
ology after tetralogy of Fallot repair is associated
with ﬁbrosis of the right ventricular outﬂow tract
visualized on cardiac magnetic resonance imag-
ing. Eur Heart J Cardiovasc Imaging 2013;14:
978–85.
30. Cameli M, Righini FM, Lisi M, et al. Comparison
of right versus left ventricular strain analysis as a
predictor of outcome in patients with systolic
heart failure referred for heart transplantation. Am
J Cardiol 2013;112:1778–84.31. Cameli M, Righini FM, Lisi M, Mondillo S.
Right ventricular strain as a novel approach to
analyze right ventricular performance in patients
with heart failure. Heart Fail Rev 2014;19:
603–10.
32. Grant AD, Smedira NG, Starling RC,
Marwich TH. Independent and incremental role of
quantitative right ventricular evaluation for the
prediction of right ventricular failure after left
ventricular assist device implantation. J Am Coll
Cardiol 2012;60:521–8.
33. Nunes MC, Abreu CD, Ribeiro AL, et al. Effect
of pacing-induced ventricular dyssynchrony on
right ventricular function. Pacing Clin Electro-
physiol 2011;34:155–62.KEY WORDS heart failure, myocardial
ﬁbrosis, right ventricle
